BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7692966)

  • 1. HIV-1 reverse transcriptase: inhibition by 2',5'-oligoadenylates.
    Sobol RW; Fisher WL; Reichenbach NL; Kumar A; Beard WA; Wilson SH; Charubala R; Pfleiderer W; Suhadolnik RJ
    Biochemistry; 1993 Nov; 32(45):12112-8. PubMed ID: 7692966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorothioate and cordycepin analogues of 2',5'-oligoadenylate: inhibition of human immunodeficiency virus type 1 reverse transcriptase and infection in vitro.
    Montefiori DC; Sobol RW; Li SW; Reichenbach NL; Suhadolnik RJ; Charubala R; Pfleiderer W; Modliszewski A; Robinson WE; Mitchell WM
    Proc Natl Acad Sci U S A; 1989 Sep; 86(18):7191-4. PubMed ID: 2476814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cordycepin analogues of 2',5'-oligoadenylate inhibit human immunodeficiency virus infection via inhibition of reverse transcriptase.
    Müller WE; Weiler BE; Charubala R; Pfleiderer W; Leserman L; Sobol RW; Suhadolnik RJ; Schröder HC
    Biochemistry; 1991 Feb; 30(8):2027-33. PubMed ID: 1705437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Affinity labeling and functional analysis of the primer binding domain of HIV-1 reverse transcriptase.
    Andreola ML; Tarrago-Litvak L; Levina AS; Kolocheva TI; el Dirani-Diab R; Jamkovoy VI; Khalimskaya NL; Barr PJ; Litvak S; Nevinsky GA
    Biochemistry; 1993 Apr; 32(14):3629-37. PubMed ID: 7682110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of DNA topoisomerase I activity by 2',5'-oligoadenylates and mismatched double-stranded RNA in uninfected and HIV-1-infected H9 cells.
    Schröder HC; Kelve M; Schäcke H; Pfleiderer W; Charubala R; Suhadolnik RJ; Müller WE
    Chem Biol Interact; 1994 Feb; 90(2):169-83. PubMed ID: 8156606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in the inhibition of human immunodeficiency virus type 1 reverse transcriptase DNA polymerase activity by analogs of nevirapine and [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro-5"-(4"-amino-1", 2"-oxathiole-2",2"-dioxide] (TSAO).
    Arion D; Fletcher RS; Borkow G; Camarasa MJ; Balzarini J; Dmitrienko GI; Parniak MA
    Mol Pharmacol; 1996 Nov; 50(5):1057-64. PubMed ID: 8913335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of morphine-potentiated HIV-1 replication in peripheral blood mononuclear cells with the nuclease-resistant 2-5A agonist analog, 2-5A(N6B).
    Homan JW; Steele AD; Martinand-Mari C; Rogers TJ; Henderson EE; Charubala R; Pfleiderer W; Reichenbach NL; Suhadolnik RJ
    J Acquir Immune Defic Syndr; 2002 May; 30(1):9-20. PubMed ID: 12048358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (2'-5')Oligoadenylate and intracellular immunity against retrovirus infection.
    Schröder HC; Suhadolnik RJ; Pfleiderer W; Charubala R; Müller WE
    Int J Biochem; 1992; 24(1):55-63. PubMed ID: 1374726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of HIV-1 replication and activation of RNase L by phosphorothioate/phosphodiester 2',5'-oligoadenylate derivatives.
    Sobol RW; Henderson EE; Kon N; Shao J; Hitzges P; Mordechai E; Reichenbach NL; Charubala R; Schirmeister H; Pfleiderer W
    J Biol Chem; 1995 Mar; 270(11):5963-78. PubMed ID: 7890727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.
    Furman PA; Fyfe JA; St Clair MH; Weinhold K; Rideout JL; Freeman GA; Lehrman SN; Bolognesi DP; Broder S; Mitsuya H
    Proc Natl Acad Sci U S A; 1986 Nov; 83(21):8333-7. PubMed ID: 2430286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity of HIV-1 reverse transcriptase and its mutants to inhibition by azidothymidine triphosphate.
    Carroll SS; Geib J; Olsen DB; Stahlhut M; Shafer JA; Kuo LC
    Biochemistry; 1994 Mar; 33(8):2113-20. PubMed ID: 7509634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substrate inhibition of the human immunodeficiency virus type 1 reverse transcriptase.
    Furman PA; Painter G; Wilson JE; Cheng N; Hopkins S
    Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6013-7. PubMed ID: 1712479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus type 1 reverse transcriptase dimer destabilization by 1-[Spiro[4"-amino-2",2" -dioxo-1",2" -oxathiole-5",3'-[2', 5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]]]-3-ethylthy mine.
    Sluis-Cremer N; Dmitrienko GI; Balzarini J; Camarasa MJ; Parniak MA
    Biochemistry; 2000 Feb; 39(6):1427-33. PubMed ID: 10684624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the p66/p51 form of human immunodeficiency virus reverse transcriptase by tRNA(Lys).
    Bordier B; Tarrago-Litvak L; Sallafranque-Andreola ML; Robert D; Tharaud D; Fournier M; Barr PJ; Litvak S; Sarih-Cottin L
    Nucleic Acids Res; 1990 Feb; 18(3):429-36. PubMed ID: 1689823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interference with HIV-1 reverse transcriptase-catalyzed DNA chain elongation by the 5'-triphosphate of the carbocyclic analog of 2'-deoxyguanosine.
    Parker WB; White EL; Shaddix SC; Ross LJ; Shannon WM; Secrist JA
    Antiviral Res; 1992 Oct; 19(4):325-32. PubMed ID: 1281392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2',5'-oligoadenylates inhibit relaxation of supercoiled DNA by calf thymus DNA topoisomerase I.
    Castora FJ; Erickson CE; Kovács T; Lesiak K; Torrence PF
    J Interferon Res; 1991 Jun; 11(3):143-9. PubMed ID: 1655915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of human immunodeficiency virus type 1 reverse transcriptase with primer tRNALys3 and affinity modification of the enzyme by tRNALys3 derivatives.
    Nevinsky GA; Zakharova OD; Fournier M; Andreola ML; Litvak S; Tarrago-Litvak L
    Eur J Biochem; 1996 Sep; 240(3):774-80. PubMed ID: 8856083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of a polynucleotide binding region in the HIV-1 reverse transcriptase: implications for primer binding.
    Sobol RW; Suhadolnik RJ; Kumar A; Lee BJ; Hatfield DL; Wilson SH
    Biochemistry; 1991 Nov; 30(44):10623-31. PubMed ID: 1718424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of HIV-1 reverse transcriptase by pyridinone derivatives. Potency, binding characteristics, and effect of template sequence.
    Carroll SS; Olsen DB; Bennett CD; Gotlib L; Graham DJ; Condra JH; Stern AM; Shafer JA; Kuo LC
    J Biol Chem; 1993 Jan; 268(1):276-81. PubMed ID: 7677997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allosteric inhibition of human immunodeficiency virus type 1 reverse transcriptase by tetrahydroimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one and -thione compounds.
    Debyser Z; Pauwels R; Andries K; Desmyter J; Engelborghs Y; Janssen PA; De Clercq E
    Mol Pharmacol; 1992 Jan; 41(1):203-8. PubMed ID: 1370707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.